Group One Trading, L.P. 2seventy Bio, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.09 - $6.0 $10,595 - $20,574	3,429 Added 37.54%	12,564 $67,000
Q4 2023 Feb 14, 2024	BUY	$1.57 - $4.58 $12,246 - $35,724	7,800 Added 584.27%	9,135 $39,000
Q3 2023 Nov 09, 2023	BUY	$3.14 - $11.2 $4,191 - $14,951	1,335 New	1,335 $5,000
Q2 2022 Aug 11, 2022	SELL	$10.55 - $18.81 $42,716 - $76,161	-4,049 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$11.67 - $26.72 $601,611 - $1.38 Million	-51,552 Reduced 92.72%	4,049 $69,000
Q4 2021 Feb 11, 2022	BUY	$13.77 - $42.56 $765,625 - $2.37 Million	55,601 New	55,601 $1.43 Million

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $113M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.